Nuvo Pharmaceuticals Inc
F:23N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
Lagardere SA
PAR:MMB
|
FR |
|
Lifeline SPAC I Oyj
F:0CD
|
FI |
|
Secom Co Ltd
F:XSC
|
JP |
|
E
|
Equinix Inc
F:EQN2
|
US |
|
C
|
CME Group Inc
XMUN:MX4A
|
US |
|
F
|
First Industrial Realty Trust Inc
F:F5W
|
US |
|
S
|
Salesforce Inc
DUS:FOO
|
US |
Intrinsic Value
The intrinsic value for
Nuvo Pharmaceuticals Inc (23N) under the Base Case is hidden
EUR.
Compared with the current market price of 0.9 EUR, the stock appears hidden
.
Do our valuations actually work? See backtest results .
23N looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 23N usually does or if today's premium is unusual.
See where today’s valuation sits in 23N’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Nuvo Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Nuvo Pharmaceuticals Inc
Earnings Waterfall
Nuvo Pharmaceuticals Inc
The intrinsic value for
Nuvo Pharmaceuticals Inc (23N) under the Base Case is hidden EUR.
Compared with the current market price of 0.9 EUR, the stock appears hidden.